Tuesday, 27 February 2018

Roche says hemophilia drug Hemlibra wins EU approval

ZURICH (Reuters) - Swiss group Roche said on Tuesday the European Commission has approved its drug Hemlibra for people with hemophilia A who have developed resistance to standard treatments.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)